Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 57.78
+0.50 (0.87%)
Apr 29, 2026, 3:04 PM CST
Intco Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 668.01 | 1,011 | 1,465 | 383 | 629.07 | 7,430 | Upgrade
|
| Depreciation & Amortization | 964.69 | 964.69 | 862.47 | 723.5 | 629.94 | 368.62 | Upgrade
|
| Other Amortization | 3.48 | 3.48 | 2.07 | 0.03 | 1.14 | 0.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.4 | 0.4 | -0.22 | -0.21 | -2.37 | -0.38 | Upgrade
|
| Asset Writedown & Restructuring Costs | -303.69 | -303.69 | 196.69 | 51.03 | 37.53 | 93.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -383.36 | -383.36 | -407.52 | -263.01 | -151.91 | -61.12 | Upgrade
|
| Other Operating Activities | 728.22 | 501.37 | -103.83 | 26.83 | -198.22 | 96.04 | Upgrade
|
| Change in Accounts Receivable | 107.53 | 107.53 | -1,103 | -606.63 | 195.71 | 185.55 | Upgrade
|
| Change in Inventory | -82.25 | -82.25 | -190.52 | -151.44 | 55.29 | -240.93 | Upgrade
|
| Change in Accounts Payable | 224.87 | 224.87 | 385.37 | 430.85 | -190.87 | -314.25 | Upgrade
|
| Change in Other Net Operating Assets | 37.48 | 37.48 | 9.63 | 8.15 | 6.01 | 43.38 | Upgrade
|
| Operating Cash Flow | 1,769 | 1,885 | 1,079 | 502.41 | 1,065 | 8,680 | Upgrade
|
| Operating Cash Flow Growth | 33.71% | 74.69% | 114.78% | -52.85% | -87.72% | 1.04% | Upgrade
|
| Capital Expenditures | -2,386 | -2,575 | -1,789 | -1,439 | -1,715 | -5,444 | Upgrade
|
| Sale of Property, Plant & Equipment | 112.48 | 112.53 | 2.54 | 16.81 | 67.28 | 5.58 | Upgrade
|
| Divestitures | - | - | - | - | - | 4.6 | Upgrade
|
| Investment in Securities | -7,506 | -9,380 | -2,336 | -2,638 | -297.13 | -2,325 | Upgrade
|
| Other Investing Activities | 257.08 | 390.42 | 255.13 | 83.86 | 78.45 | 28.48 | Upgrade
|
| Investing Cash Flow | -9,523 | -11,452 | -3,868 | -3,976 | -1,867 | -7,730 | Upgrade
|
| Long-Term Debt Issued | - | 21,096 | 14,060 | 7,896 | 1,849 | 560.29 | Upgrade
|
| Long-Term Debt Repaid | - | -16,960 | -8,016 | -2,312 | -563.75 | -438.03 | Upgrade
|
| Net Debt Issued (Repaid) | 2,677 | 4,136 | 6,044 | 5,583 | 1,286 | 122.26 | Upgrade
|
| Issuance of Common Stock | 148.83 | 148.83 | - | - | 66.45 | - | Upgrade
|
| Repurchase of Common Stock | -78.17 | -78.17 | -25.83 | - | - | -1.41 | Upgrade
|
| Common Dividends Paid | -494.05 | -422.17 | -338.28 | -184.92 | -457.11 | -1,074 | Upgrade
|
| Other Financing Activities | 4,375 | 4,593 | -4,255 | -2,389 | -346.04 | 119.95 | Upgrade
|
| Financing Cash Flow | 6,629 | 8,378 | 1,425 | 3,009 | 549.05 | -833.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | -396.79 | -306.41 | 59.85 | 67.05 | 271.8 | -41.77 | Upgrade
|
| Net Cash Flow | -1,522 | -1,495 | -1,304 | -397.43 | 19.69 | 74.8 | Upgrade
|
| Free Cash Flow | -617.19 | -689.72 | -710.37 | -936.28 | -649.76 | 3,236 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -43.12% | Upgrade
|
| Free Cash Flow Margin | -5.98% | -6.95% | -7.46% | -13.53% | -9.82% | 19.93% | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -1.07 | -1.10 | -1.42 | -0.98 | 4.79 | Upgrade
|
| Cash Income Tax Paid | - | -157.97 | -440.36 | -327.53 | -729.81 | -335.24 | Upgrade
|
| Levered Free Cash Flow | -660.06 | -635.31 | -1,275 | -1,447 | -994.12 | -230.09 | Upgrade
|
| Unlevered Free Cash Flow | -428.72 | -404.59 | -1,082 | -1,367 | -976.33 | -219.09 | Upgrade
|
| Change in Working Capital | 91.45 | 91.45 | -936.08 | -418.76 | 120.3 | 753.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.